Summary
Cardinal Health, Inc. (CAH) filed a Form 8-K on February 22, 2013, to report a significant debt offering. The company successfully issued and sold a total of $1.3 billion in aggregate principal amount of senior notes across three tranches: $400 million of 1.700% notes due 2018, $550 million of 3.200% notes due 2023, and $350 million of 4.600% notes due 2043. This offering, conducted under the company's effective Form S-3 registration statement, involved an underwriting agreement with Merrill Lynch, Deutsche Bank Securities, and UBS Securities as representatives of the underwriters. This debt issuance indicates Cardinal Health's strategic move to raise capital, likely to fund operations, support growth initiatives, or manage its existing debt structure. The varying maturity dates and interest rates suggest a diversified approach to debt financing, allowing the company to manage its interest expense and cash flow needs over different time horizons. Investors should note the specific terms and covenants associated with these notes, which are further detailed in the incorporated exhibits such as the Underwriting Agreement and the forms of the notes themselves.
Key Highlights
- 1Cardinal Health issued $1.3 billion in aggregate principal amount of senior notes.
- 2The offering included three tranches: $400M of 1.700% notes due 2018, $550M of 3.200% notes due 2023, and $350M of 4.600% notes due 2043.
- 3The debt issuance was made under Cardinal Health's effective Form S-3 registration statement.
- 4The notes were sold on February 22, 2013.
- 5Key underwriters included Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank Securities Inc., and UBS Securities LLC.
- 6The filing provides details on the Underwriting Agreement and forms of the notes as exhibits.